Mar 29 2010
Sinovac Biotech Ltd. ( SVA),
a leading China-based vaccine manufacturer, announced today it has entered
into exclusive license, supply and distribution agreements with Parenteral
Biotech Ltd., a subsidiary of Parenteral Drugs (India), Ltd., an India-based
pharmaceutical company. Pursuant to the agreements, Parenteral is authorized
to register, supply and distribute Sinovac's Anflu (seasonal influenza vaccine)
and PANFLU.1 (H1N1 vaccine) to the government of India and private market in
India. Currently, the registration process is ongoing in India.
Parenteral intends to apply to the Drug Controller General of India (DCGI)
for the import approval for the vaccines. The volume, delivery schedule and
other specific details about how Sinovac's vaccines may be marketed and
supplied to the government of India and the private market in India have not
been determined.
Mr. Weidong Yin, Chairman, President and CEO of Sinovac, stated, "The
agreements correspond with Sinovac's international marketing strategy to
partner with established local suppliers to secure regulatory approval and
more efficiently facilitate distribution in numerous international markets. We
look forward to partnering with Parenteral Biotech to bring our seasonal
influenza vaccine and H1N1 vaccine to the people of India."